All human papillomavirus articles
-
NewsScientists uncover how HPV-positive cancers hide from the immune system — and how to make them visible again
A new study solves a major mystery in cancer immunology by uncovering how HPV hides cancer cells from the immune system by using MARCHF8 to destroy MHC-I, which serves as a warning flag for the immune system.
-
NewsTesting menstrual blood for HPV could be “robust alternative” to cervical screening
Testing menstrual blood for human papillomavirus (HPV) could be a “robust alternative or replacement” for current cervical cancer screening by a clinician, finds a study. The researchers say using menstrual blood for HPV testing is convenient and non-invasive.
-
NewsStudy suggests far fewer cervical cancer screenings are needed for HPV‑vaccinated women
In a modeling study of women vaccinated against human papillomavirus (HPV), researchers found that cervical cancer screening could be done far less often than current recommendations without compromising health benefits.
-
NewsNew hypothesis links HPV E6 and SARS‑CoV‑2 spike proteins to reduced p53 activity
Scientists have proposed a hypothesis suggesting that virally encoded proteins such as HPV-E6 or SARS-COV-2 Spike may cooperate in suppressing host defenses including tumor suppressor mechanisms involving p53.
-
NewsSingle-cell insights reveal how HPV status reshapes penile tumor immunity
A study found that HPV-positive tumors in penile squamous cell carcinoma cases contained fewer proliferative macrophages and less exhausted CD8+ T cells, along with stronger chemokine signaling, revealing distinct immune remodeling associated with HPV infection.
-
NewsStudent’s unexpected rise as a researcher leads to critical new insights into HPV
In two years, a student went from lab novice to medical diagnostics honors student whose study revealed how mutations in HPV proteins may increase cancer risk.
-
NewsSome acute and chronic viral infections may increase the risk of cardiovascular disease
In the weeks following a bout of influenza or COVID, the risk of heart attack or stroke may rise dramatically, and chronic infections such as HIV may increase the long-term risk of serious cardiovascular disease events, according to new, independent research.
-
NewsEurope backs first cervical cancer vaccination campaign in Angola
Angola’s first national vaccination campaign will immunise over 2 million girls aged 9–12 against cervical cancer. The national rollout began this week with coordinated delivery across schools, clinics, and communities in all 21 provinces.
-
NewsNew one-hour, low-cost HPV test could transform cervical cancer screening in Africa and beyond
A team of researchers has developed a simple, affordable human papillomavirus (HPV) test that delivers results in less than an hour with no specialized laboratory required.
-
NewsStudy shows HPV vaccine protects vaccinated — and unvaccinated — women
A study has found that the introduction of the human papillomavirus (HPV) vaccine in community settings is highly effective in protecting young women from infections caused by the cervical-cancer-causing virus—including women who didn’t even receive the vaccine.
-
NewsAdverse event profiles following HPV vaccination in males
The safety profile among male recipients of human papillomavirus (HPV) vaccination remains a critical evidence gap. A new study presents the first systematic safety evaluation of Gardasil 9 and Gardasil in male recipients.
-
NewsHPV integration: Moving from carcinogenesis mechanisms to clinical applications
The clinical significance of HPV integration into the host genome is substantial, particularly in cervical cancer screening programs. Integration testing has emerged as a valuable triage tool for detecting high-grade cervical intraepithelial neoplasia (CIN III+).
-
NewsBlood test identifies HPV-associated head and neck cancers up to 10 years before symptoms
Researchers show that a novel liquid biopsy tool called HPV-DeepSeek can identify HPV-associated head and neck cancer up to 10 years before symptoms appear.
-
NewsDNA analysis shows colorectal cancer has unique microbial fingerprint
Colorectal cancer is unique in having its own microbial ‘fingerprint’ – according to new research that could help doctors better understand how this cancer develops, how aggressive it might be, and even how a patient might respond to treatment.
-
NewsSeroprevalence 36 months after a single-dose bivalent HPV vaccination among nine to fifteen-year-old girls
A single-dose bivalent HPV vaccine induces sustained immunity in Bangladeshi adolescent girls, with lower HPV16 seropositivity among older girls and those in higher grades, with higher HPV18 seropositivity linked to lower household income.
-
NewsEpstein-Barr virus protein EBNA1 upregulates oncogenes in cervical cancer cells
New findings suggest that increased expression levels of Derlin1 and PSMD10 genes in HeLa cells by the EBV-EBNA1 might induce cancer cell survival and accelerates the development of cervical cancer (CC).
-
News1 in 3 US adults unaware of connection between HPV and cancers
The human papillomavirus (HPV) can cause six types of cancer, yet new analysis shows that most people are unaware of the connection between HPV and all of these cancers.
-
NewsEngineers develop electrochemical sensors for cheap, disposable diagnostics
Electrodes coated with DNA could enable inexpensive tests with a long shelf-life, which could detect many diseases and be deployed in the doctor’s office or at home.
-
NewsHPV drives tumor development in rare nasal cancers
Human papillomavirus (HPV) can drive tumor development in some rare sinonasal squamous cell carcinomas (SNSCCs), according to a new comprehensive study of these tumors from investigators who also identified common mutations among these cancers and a potential combination treatment.
-
NewsNew blood test shows superior sensitivity in detecting HPV-associated head and neck cancers
A new liquid biopsy blood test could help detect cases of human papillomavirus (HPV)-associated head and neck cancers with significantly higher accuracy than currently used methods, including before patients develop symptoms.